Include All CSL Behring Country Sites

News Room

The most recent items of news in the Canadian Region are:

Rare Disease Day February 28th 2017
Ottawa – CSL Behring Canada staff raise and join their hands in support of patients with Rare Disease. Raise and Join your hands for Rare Disease Day February 28th 2017. More.

Health Canada Approves CSL Behring’s AFSTYLA for the Treatment of Hemophilia A
Health Canada has approved AFSTYLA [Antihemophilic Factor VIII (Recombinant), SingleChain], CSL Behring’s novel long-lasting recombinant factor VIII single-chain therapy for adults and children with hemophilia A. More.